Additionally, our functional data suggest the utility of high ALDH3A1 expression as a putative diagnostic marker for stemness in glioma as indicated by reduced expression of CD133, Nestin and Sox2 as well as diminished clonogenicity in response to ALDH3A1 inhibition. The gene discussed is SOX2; the disease is central nervous system cancer.